Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Oncotarget|December 10, 2015
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionJulien Masliah-Planchon, Simon Garinet, Eric PasmantJournal of Clinical Medicine|June 13, 2018
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?Simon Garinet, Pierre Laurent-Puig, Hélène Blons, et al.Journal of Thoracic Disease|February 19, 2019
Molecular markers and prediction of response to immunotherapy in non-small cell lung cancer, an updateHélène Blons, Simon Garinet, Pierre Laurent-Puig, et al.Cell Reports|August 12, 2023
Genome-guided discovery of cancer therapeutic targetsPrathyusha Konda, Simon Garinet, Eliezer M Van Allen, et al.Biomolecules|July 26, 2020
Epigenetic Mechanisms of Resistance to Immune Checkpoint InhibitorsAlexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, et al.Clinical Biochemistry|February 4, 2014
Differential interferences of hemoglobin and hemolysis on insulin assay with the Abbott Architect-Ci8200 immunoassaySimon Garinet, Soraya Fellahi, Ginette Marlin, et al.Genes, Chromosomes & Cancer|November 13, 2021
Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E-mutated and microsatellite unstable metastatic colorectal cancer patient: A case reportClaire Gallois, Julien Taieb, Annabelle Sabouret, et al.Cancers|March 25, 2022
Updated Prognostic Factors in Localized NSCLCSimon Garinet, Pascal Wang, Audrey Mansuet-Lupo, et al.Critical Reviews in Oncology/Hematology|February 8, 2025
Molecular features and clinical actionability of gene fusions in colorectal cancerFrancesco Giulio Sullo, Simon Garinet, Hélène Blons, et al.Bulletin Du Cancer|August 9, 2020
[Fusion transcripts: Therapeutic targets in thoracic oncology]Audrey Mansuet-Lupo, Simon Garinet, Diane Damotte, et al.Pageof 5